Endocrinology

Endocrinology is the study of the endocrine system which helps to regulate metabolism and growth. Surveys and online discussions in this area cover subjects such as trends in use of insulin pumps; Type 2 diabetes treatment options; tracking studies of Byetta, and the impact of Januvia and Galvus on Type 2 diabetes marketplace.
Reports become free one year after publication date.

 

Report Name	Report Type	Specialty	Publish Date
Byetta Wave 4 Tracking Survey; Trends in Usage of Type II Diabetes Mellitus Therapeutics	Survey	Endocrinology	Jun 18, 2008	FREE
To periodically track changes in usage of Byetta® (exenatide) by surveying a set of endocrinologists and primary care physicians regarding their current and future practices in treatment of type II diabetes mellitus Determine the current market share held by Byetta® and...
Diabetes: GLP-1 Analogues, DPP-IV Inhibitors & Insulins Trends in Use	Survey	Endocrinology	Sep 10, 2007	FREE
To provide an overview of current type II diabetes mellitus (T2DM) treatment practices and the near-term market outlook for a set of companies and key therapeutic products in development. Additionally: Focus on experience with and outlook for three key drugs and classes:...
Insulin Analogues: Market Assessment	Discussion	Endocrinology	Aug 14, 2007	FREE
Panel Intelligence engaged a panel of ten endocrinologists and primary care physicians to: Evaluate the growth in the diabetes market, specifically focused on insulin analogues. Areas investigated: o Choice of product by patient type and other decision drivers...
Insulin Pumps: Trends in Use	Discussion	Endocrinology	Aug 14, 2007	FREE
To conduct a panel among diabetologists to discuss the use of continuous subcutaneous insulin injection therapy in patients with type 1 and type 2 diabetes. The primary goals are to understand current treatment practices and market dynamics involving insulin pumps, and to determine physician and...
Diabetic Foot Infection (Mild): Trends in Treatment	Discussion	Endocrinology	Jun 14, 2007	FREE
Panel Intelligence engaged a panel of podiatrists in a discussion designed to understand the perception and potential use of Microcyn® technology for the treatment of mild diabetic foot infections. Uncover current treatment patterns for mild diabetic foot infections ...
American Diabetes Association 2007 Leadership Summit	Discussion	Endocrinology	Jun 14, 2007	FREE
Discuss the GLP-1 analogues: the current use of exenatide, the status of exenatide LAR and an update on liraglutide. Review the use of DPP-IV inhibitors Current practice with Januvia Status of Galvus Market of DPP-IV inhibitors ...
TRT for Hypogonadism	Discussion	Endocrinology	Mar 28, 2007	FREE
n Compare and contrast current treatment options for testosterone replacement therapy (TRT) n Elicit expert feedback on testosterone undecanoate (Indevus’s Nebido) n Clarify potential utilization of testosterone undecanoate Products...
Discussion Diabetes-Byetta Usage and Diabetes Market Trends_MAR2007	Discussion	Endocrinology	Mar 7, 2007	FREE
Determine current treatment patterns, recent market dynamics, and future trends with the mix of leading Type 2 therapies, including Byetta (exenatide), Januvia (sitagliptin) and Other standards of care (metformin, TZD’s, sulfonylureas, insulin) ...
Impact of Januvia and Galvus on Type 2 Diabetes Market	Discussion	Endocrinology	Dec 17, 2006	FREE
Elicit prescribers’ perceptions of Januvia Determine the facilitators and barriers to Januvia use Understand the typical Januvia patient profile Establish the impact of Januvia’s approval on the use of other agents (Actos/Avandia, Insulin, Byetta) and expected trends Ascertain...
Type 2 Diabetes Therapies Assessment	Discussion	Endocrinology	Dec 14, 2006	FREE
Determine current usage/allocation of the mix of leading Type 2 therapies Understand utilization Understand physician prescribing experience with exenatide Assess impact of sitagliptin on treatment algorithms Gather impressions of inhaled insulin Products Highlighted: ...
Evaluation of Byetta	Survey	Endocrinology	Jul 30, 2006	FREE
To assess current physician opinion and prescribing practices of Byetta for patients with type II diabetes To evaluate current patient perceptions of Byetta To estimate future use of Byetta over the next twelve months To gauge physician awareness and familiarity with...
ADA Diabetes Forum	Discussion	Endocrinology	Jun 20, 2006	FREE
To examine data emerging from the American Diabetes Association’s (ADA) 66th Annual Scientific Sessions To investigate strengths and weaknesses associated with diabetes treatments currently in development To prioritize treatment objectives for diabetic patients Products...

 

 

about us       contact us

© MedPanel, LLC. 1999-2010. All rights reserved. Privacy Policy